Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Shionogi Licenses Rapid COVID-19 Diagnostic Methods Developed by 3 Universities
Shionogi said on June 22 that it has entered into a license agreement with three Japanese universities for the rights to develop and commercialize a new rapid diagnostic method for viruses including the novel coronavirus (SARS-CoV-2). The company aims to…
To read the full story
Related Article
- Shionogi Delays Saliva-Based COVID-19 Test Launch to December
September 25, 2020
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





